Reducing the Incidence of Colorectal Cancer
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The prevalence of colorectal cancer could be reduced by 95% with proper screening in every patient at recommended age intervals. That’s according to Dr. Steven Stryker, professor of clinical surgical oncology at Northwestern University’s Feinberg School of Medicine. Yet colorectal cancer remains the second most common cancer in America. Dr. Stryker joins host Dr. Lauren Streicher to explain how physicians can encourage patient compliance with current screening modalities. What circumstances favor virtual screening? Are there other common procedures that can facilitate the diagnosis of colorectal cancer?
Overview
The prevalence of colorectal cancer could be reduced by 95% with proper screening in every patient at recommended age intervals. That’s according to Dr. Steven Stryker, professor of clinical surgical oncology at Northwestern University’s Feinberg School of Medicine. Yet colorectal cancer remains the second most common cancer in America. Dr. Stryker joins host Dr. Lauren Streicher to explain how physicians can encourage patient compliance with current screening modalities. What circumstances favor virtual screening? Are there other common procedures that can facilitate the diagnosis of colorectal cancer?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Partnering with Patients: Building Effective Communication and Support in HF Care
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Pulmonary Hypertension Management: Practice Trends and Updates
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?